Amid increasing concerns about the quality and safety of kratom products, industry leaders are advocating for the U.S. Food and Drug Administration (FDA) to establish a regulatory framework. The American Kratom Association (AKA) and other stakeholders argue that FDA oversight is essential to ensure consumer protection and product consistency in the rapidly expanding market.
The push for regulation comes as the kratom industry faces scrutiny over the lack of standardized quality controls, which can lead to contamination and inconsistent potency. By implementing FDA regulations, proponents believe it will enhance the credibility of kratom products and provide clearer guidelines for manufacturers and consumers alike.
For more details, read the full article on Benzinga here.